Hifumed Announces Real-World Data Analytics Service Leveraging Longitudinal Dermatology Patient Data

あなたが現在見ているのは Hifumed Announces Real-World Data Analytics Service Leveraging Longitudinal Dermatology Patient Data

Supporting medication-specific treatment analysis using up to approximately two years of clinical histories and longitudinal patient-reported data collected through online dermatology services.

Hifumed Inc. (“Hifumed”) today announced its Real-World Data (RWD) Analytics Service for pharmaceutical and healthcare companies, leveraging longitudinal treatment data from patients with dermatological conditions.

Through its online dermatology services, Personal Health Record (PHR) platform, and AI-powered skin image analysis services, Hifumed has accumulated clinical information, patient-reported skin conditions, and treatment history data.

Building on these data assets and its analytical expertise, Hifumed is expanding into enterprise-focused RWD analytics.

The service combines electronic medical records with longitudinal patient-reported data, including skin conditions, medication usage, quality of life (QOL), and skin images, to analyze treatment patterns and patient journeys over time by medication and disease.

By examining treatment persistence, patient treatment behavior, and physicians’ prescribing patterns, Hifumed aims to provide real-world insights that support decision-making in the pharmaceutical industry.

Background and Significance

Chronic dermatological conditions, including atopic dermatitis, often involve recurring periods of symptom improvement and worsening. Understanding long-term treatment journeys is therefore essential.

While traditional electronic medical records and healthcare claims data provide information on clinical visits and prescriptions, they may not fully capture changes in symptoms or actual medication usage between consultations.

Understanding why patients continue or discontinue treatment, as well as how physicians select or modify medications in routine clinical practice, is also important.

Hifumed has been collecting longitudinal patient data by combining online dermatology consultations with ongoing patient-reported health records.

By leveraging these accumulated data, Hifumed aims to help pharmaceutical and healthcare companies better understand real-world medication usage and patient treatment journeys.

 

Overview of Hifumed's RWD Analytics Service

Hifumed’s RWD Analytics Service integrates clinical information collected through online dermatology consultations with patient-reported symptoms and medication usage records to analyze treatment journeys over time.

The service utilizes three primary categories of data.

1. Longitudinal Skin Monitoring and Medication Usage Data (PHR)

Hifumed analyzes patient-recorded changes in skin conditions, skin images, medication names, frequency of medication use, and observations from daily life.

These data help provide insights into symptom fluctuations and actual medication usage between clinical consultations.

2. Patient Questionnaires and Quality-of-Life Data

The service analyzes patient-reported information, including affected body areas, symptom progression, aggravating factors, Dermatology Life Quality Index (DLQI) scores, and treatment preferences.

These analyses help identify the impact of dermatological conditions on patients’ daily lives, their understanding of treatment, and their treatment-related needs.

They also support the evaluation of relationships between patient-reported factors, treatment behavior, and treatment persistence.

3. Electronic Medical Records and Clinical History Data

Hifumed analyzes clinical information, including diagnoses, physicians’ clinical observations, prescriptions, medication changes, consultation dates, and follow-up visits.

These data help identify prescribing patterns and treatment modifications in relation to patients’ documented conditions and clinical progress.

They also support the analysis of treatment persistence and follow-up consultation patterns.

Real-World Treatment Analysis by Medication and Disease

The service primarily focuses on medication-specific analyses while also supporting disease-specific assessments and analyses of patient and physician behavior.

Its five core analytical areas include:

1. Treatment Persistence and Follow-Up Patterns

By analyzing individual consultation histories and medication usage records, Hifumed evaluates treatment persistence, intervals between follow-up visits, and patterns of treatment discontinuation.

2. Patient Understanding of Treatment and Treatment Behavior

The service examines patients’ understanding of their treatments, medication usage patterns, and consistency of symptom tracking.

These analyses explore the relationships between treatment understanding, self-management behavior, and treatment persistence.

3. Comparative Analysis of Treatment Practices in Japan and International Markets

Hifumed aims to support comparative analyses of medication selection, prescribing patterns, and treatment approaches between Japan and international markets as relevant data become available.

These analyses are intended to provide insights into regional differences in real-world dermatological treatment practices.

4. Physicians’ Prescribing Patterns and Clinical Decision-Making

By integrating diagnoses, clinical observations, prescription records, and medication modification histories, Hifumed analyzes prescribing patterns and treatment changes in relation to documented patient conditions and clinical progress.

This approach provides insights into real-world prescribing behavior and clinical decision-making patterns.

5. Longitudinal Treatment Analysis Using Skin Images

The service combines patient-recorded skin images with medication usage records, clinical histories, and QOL data to analyze changes in skin conditions over time.

By examining skin images before and after treatment alongside clinical and patient-reported information, Hifumed supports a more comprehensive understanding of patient treatment journeys.

Through these analytical capabilities, Hifumed provides pharmaceutical and healthcare companies with analytical findings and reports on patient treatment behavior, real-world medication usage, and physicians’ prescribing patterns.

Note: Available analytical parameters and observation periods vary depending on individual patient records and data availability.

 

Future Outlook

Hifumed plans to further expand its RWD analytics capabilities by leveraging patient data accumulated through its online dermatology and PHR services.

The company aims to strengthen partnerships with pharmaceutical companies, medical device manufacturers, and other healthcare organizations.

By expanding its analytical offerings to address industry needs related to real-world medication usage, treatment persistence, and prescribing patterns, Hifumed seeks to support data-driven decision-making in dermatology.

Hifumed’s long-term vision is to transform individual patients’ treatment experiences into meaningful insights that contribute to healthcare, product development, and patient support.

About Hifumed Inc.

株式会社ヒフメド
Hifumed Inc.

Business Areas

  • Online dermatology services

  • AI-powered skin image analysis

  • Real-world data analytics in dermatology

Website

https://hifu-med.com/

 

Media and Business Inquiries

株式会社ヒフメド
Hifumed Inc.

担当 / Contact: Chiaki Takahara

    必須お名前

    必須メールアドレス

    必須お問い合せ内容